FdaApplication
NDA 020818
Identifiers
- fda_app_no: NDA020818
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1998-03-06 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;320MG | TABLET;ORAL |
| DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;80MG | TABLET;ORAL |
| DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;160MG | TABLET;ORAL |
| DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;160MG | TABLET;ORAL |
| DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;320MG | TABLET;ORAL |
5 products